Inotek Pharmaceuticals Corp Stock Nasdaq
Equities
US45780V1026
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- | - |
Sales 2024 * | 26.32M 0 | Sales 2025 * | 163M 0 | Capitalization | 2.07B 0 |
---|---|---|---|---|---|
Net income 2024 * | -260M - | Net income 2025 * | -219M - | EV / Sales 2024 * | 71.4 x |
Net cash position 2024 * | 193M 0 | Net cash position 2025 * | 111M 0 | EV / Sales 2025 * | 12 x |
P/E ratio 2024 * |
-8.43
x | P/E ratio 2025 * |
-10.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.59% |
Latest transcript on Inotek Pharmaceuticals Corp
Managers | Title | Age | Since |
---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 18-01-03 |
Kinnari Patel
PSD | President | 46 | 18-01-03 |
Chief Tech/Sci/R&D Officer | 60 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pedro Granadillo
BRD | Director/Board Member | 77 | 18-01-03 |
Carsten Boess
BRD | Director/Board Member | 57 | 15-12-31 |
David Southwell
BRD | Director/Board Member | 63 | 14-07-31 |
1st Jan change | Capi. | |
---|---|---|
+8.37% | 115B | |
+13.09% | 107B | |
-13.64% | 22.31B | |
-3.99% | 21.6B | |
-5.89% | 18.23B | |
-39.93% | 17.62B | |
+7.42% | 14.26B | |
+33.28% | 12.37B | |
-28.21% | 8.28B |